Indegene Limited (INDGN) Share Price
NSE · Healthcare · Health Information Services · ISIN INE065X01017
Key metrics
- Market Cap
- ₹13,942 Cr
- P/E Ratio
- 34.83
- EPS
- 16.62
- Book Value
- 130.29
- P/B Ratio
- 4.35
- ROE
- 12.78%
- ROCE
- 15.16%
- Debt / Equity
- 0.05
- Net Margin
- 11.43%
- Revenue Growth
- 23.64%
- Profit Growth
- -1.38%
- Dividend Yield
- 0.4%
- 52W High
- ₹596.80
- 52W Low
- ₹414.00
- Market Cap Band
- mid cap
- Face Value
- 2
Ratios computed from the annual results period ending 2026-03-31.
About Indegene Limited
Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, North America, and internationally. It operates through Enterprise Medical Solutions, Enterprise Commercial Solutions, and Other segments. The company provides AI-embedded commercialization services for biopharmaceutical, emerging biotech, and medical devices companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms, as well as provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Further, it engages in the professional, and scientific and technical activities. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India.
- Headquarters
- Bengaluru, India
- Employees
- 4,687
- Promoter Holding
- 55.67%
The full Indegene Limited analysis
Create a free account to open the complete INDGN deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.